Phisoderm Clear Confidence Spot Treatment Cream
NDC Package 10742-8293-1

11-digit billing NDC: 10742829301

Package Information

Phisoderm Clear Confidence Spot Treatment (benzoyl peroxide) cream is clean skin thoroughly before applying this product cover entire affected area with a thin layer 1 to 3 times daily because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day if going outside, apply sunscreen after using this product. This formulation utilizes a cream delivery system. Marketed by The Mentholatum Company, this product is identified by NDC 10742-8293 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
10742-8293-1
Package Description
1 TUBE in 1 CARTON / 18.4 g in 1 TUBE
Product Code
11-Digit Billing Format
10742829301
RxNorm Crosswalk
  • RxCUI: 1435874 - pHisoderm clear confidence Spot Treatment 2.5 % Topical Cream
  • RxCUI: 1435874 - benzoyl peroxide 25 MG/ML Topical Cream [Phisoderm Clear Confidence Spot Treatment]
  • RxCUI: 1435874 - Phisoderm Clear Confidence Spot Treatment 2.5 % Topical Cream
  • RxCUI: 1435874 - Phisoderm Clear Confidence Spot Treatment 25 MG/ML Topical Cream
  • RxCUI: 308688 - benzoyl peroxide 2.5 % Topical Cream

Clinical Specifications

Proprietary Name
Phisoderm Clear Confidence Spot Treatment
Non-Proprietary Name
Benzoyl Peroxide
Substance Name
Benzoyl Peroxide
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Clean skin thoroughly before applying this product cover entire affected area with a thin layer 1 to 3 times daily because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor. Sensitivity Test: Apply product sparingly to a small affected area for the first 3 days. If no discomfort occurs, follow directions above.

Regulatory & Marketing

Labeler Name
The Mentholatum Company
Product Type
Human Otc Drug
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-01-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10742-8293-1 identifies a specific commercial package of 1 tube in 1 carton / 18.4 g in 1 tube of Phisoderm Clear Confidence Spot Treatment, a human over the counter drug labeled by The Mentholatum Company. This cream is formulated for topical use and contains benzoyl peroxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Mentholatum Company on August 01, 2013. The current certification is valid through December 31, 2026.

How is this The Mentholatum Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10742829301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
10742-8293-1
11-Digit CMS (5-4-2)
10742-8293-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.